Could blocking a Tumor's blood supply shrink brain meningiomas?
NCT ID NCT05416567
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This study tests a procedure called endovascular embolization for people with meningioma, a type of brain tumor. The procedure blocks blood vessels that feed the tumor, aiming to shrink it or stop its growth. Participants are adults with growing or symptomatic meningiomas that are supplied by a specific artery. The study measures tumor volume changes and tracks complications or the need for further treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a procedure called endovascular embolization that blocks blood vessels feeding the tumor
- What this could lead to
- If it works, this could offer a less invasive treatment for meningiomas, potentially avoiding surgery or radiation in some patients.
- What could go wrong
- This is a small, early study with only 30 participants, so results may not apply broadly. The procedure carries risks like bleeding or stroke.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St Olavs Hospital
RECRUITINGTrondheim, 7006, Norway
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- Drug combo aims to shrink NF2 tumors and save hearing
- Radiation's hidden toll on the brain: new study maps cognitive changes to protect patients
- New combo aims to stall aggressive brain tumors when surgery and radiation fail
- New MRI dye could spot aggressive brain tumors without surgery